Rita Horvath

ANDREA RITA HORVATH MD, PhD, EuSpLM, FRCPath, FRCPA, is Clinical Director at the Department of Clinical Chemistry and Endocrinology of New South Wales Health Pathology, based at the Prince of Wales Hospital in Sydney. She is Conjoint Professor of Medicine at the University of New South Wales, and Visiting Fellow at the Australian Institute of Health Innovation of Macquarie University. She holds Honorary Professorship at the School of Public Health of Sydney University.

Key research interest: evidence-based laboratory medicine (EBLM) including evidence-based monitoring, guideline development, evaluation of new biomarkers and overdiagnosis.

Advisory roles on test utilization and reimbursement policy: National Prescribing Service of Australia and Medicare.

Publication records: 160 research papers; 16 book chapters; invited speaker at over 100 international conferences. Senior editor of the 6th edition of the Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, published in 2017.

National and international leadership positions: Chair of the IFCC Committee on EBLM (2003-2008); European Communities Confederation of Clinical Chemistry and Laboratory Medicine (EC4) Secretary (2005-2007); President of the Hungarian Society (2005-2008) and the Hungarian College of Laboratory Medicine (2008-2009); President-Elect (2007-2009), President (2009-2011) and Past President (2012-2013) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM); chair of the EFLM working group on Test Evaluation (2011-2015) and member of the Board of Directors of the American Association of Clinical Chemistry (2014-2016).